Stephen R Brady's Net Worth
$105 Thousand
Who is Stephen R Brady?
Stephen R Brady does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include IMMUNE DESIGN CORP., Tempest Therapeutics, Inc., and Atreca, Inc..
SEC CIK
Stephen R Brady's CIK is 0001606241
Past Insider Trading and Trends
2018 was Stephen R Brady's most active year for acquiring shares with 12 total transactions. Stephen R Brady's most active month to acquire stocks was the month of December. 2018 was Stephen R Brady's most active year for disposing of shares, totalling 10 transactions. Stephen R Brady's most active month to dispose stocks was the month of June. 2024 saw Stephen R Brady paying a total of $73,850.00 for 285,000 shares, this is the most they've acquired in one year. In 2019 Stephen R Brady cashed out on 623,298 shares for a total of $108,540.45, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
IMMUNE DESIGN CORP. No price found
EVP, Strategy & FinanceStephen R Brady used to own units in Common Stock but no longer holds any shares there.acquired a total of 106,453 shares in IMMUNE DESIGN CORP. at a cost of $10,255.35, Stephen also disposed a total of 27,549 shares of IMMUNE DESIGN CORP. equalling to $131,209.90.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -17.06K |
$5.85 | -$99,818.55 |
0
|
Apr 2
| |||
Form 4
| +25.27% | 19.48K |
$1.58 | -$8,721.90 | 96.6K |
Scheduled
|
Jan 3 - Jan 7
| ||
Form 4
| +63.51% | 29.95K |
—
|
—
| 77.11K |
Nov 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 17
| |||
Form 4
| +54.68% | 16.67K |
$4.17 | -$13,884.75 | 47.16K |
Scheduled
|
Jan 4 - Jan 5
| ||
Form 4
| +77.97% | 13.36K |
$5.35 | -$8,784.70 | 30.49K |
Scheduled
|
Jan 4
| ||
Form 4
| +9.60% | 1.5K |
$6.84 | $10,255.35 | 17.13K |
Jul 15
| |||
Form 4
| +2,373.42% | 15K |
—
|
—
| 15.63K |
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Tempest Therapeutics, Inc. (TPST) Snapshot price: $1.25
President and CEOStephen R Brady owns 46,376 units of Common Stock which is worth $57,970.00. From 2021 to 2024 Stephen R Brady acquired a total of 35,000 shares in Tempest Therapeutics, Inc. at a cost of $73,850.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +307.67% | 35K |
$2.11 | $73,850.00 | 46.38K |
Jul 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Atreca, Inc. (BCEL) Snapshot price: $0.09
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||